Mechanism of activation of a human oncogene - PubMed (original) (raw)

. 1982 Nov 11;300(5888):143-9.

doi: 10.1038/300143a0.

• PMID: 6290897
• DOI: 10.1038/300143a0

Mechanism of activation of a human oncogene

C J Tabin et al. Nature. 1982.

Abstract

The oncogene of the human EJ bladder carcinoma cell lines arose via alteration of a cellular proto-oncogene. Experiments are presented that localize the genetic lesion that led to activation of the oncogene. The lesion has no affect on levels of expression of the oncogene. Instead, it affects the structure of the oncogene-encoded protein.

PubMed Disclaimer

Similar articles

• Spontaneous activation of a human proto-oncogene.
  Santos E, Reddy EP, Pulciani S, Feldmann RJ, Barbacid M. Santos E, et al. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4679-83. doi: 10.1073/pnas.80.15.4679. Proc Natl Acad Sci U S A. 1983. PMID: 6308640 Free PMC article.
• Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.
  Parada LF, Tabin CJ, Shih C, Weinberg RA. Parada LF, et al. Nature. 1982 Jun 10;297(5866):474-8. doi: 10.1038/297474a0. Nature. 1982. PMID: 6283357
• Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.
  Yuasa Y, Srivastava SK, Dunn CY, Rhim JS, Reddy EP, Aaronson SA. Yuasa Y, et al. Nature. 1983 Jun 30;303(5920):775-9. doi: 10.1038/303775a0. Nature. 1983. PMID: 6866079
• Transforming genes of tumor cells.
  Weinberg RA. Weinberg RA. Int Rev Cytol Suppl. 1983;15:191-202. doi: 10.1016/b978-0-12-364376-6.50013-2. Int Rev Cytol Suppl. 1983. PMID: 6343283 Review. No abstract available.
• Transforming genes in human tumors.
  Pulciani S, Santos E, Lauver AV, Long LK, Barbacid M. Pulciani S, et al. J Cell Biochem. 1982;20(1):51-61. doi: 10.1002/jcb.240200106. J Cell Biochem. 1982. PMID: 6761348 Review.

Cited by

• Large-scale multi-omic analysis identifies noncoding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma.
  Zhong J, O'Brien A, Patel M, Eiser D, Mobaraki M, Collins I, Wang L, Guo K, TruongVo T, Jermusyk A, O'Neill M, Dill CD, Wells AD, Leonard ME, Pippin JA, Grant SFA, Zhang T, Andresson T, Connelly KE, Shi J, Arda HE, Hoskins JW, Amundadottir LT. Zhong J, et al. medRxiv [Preprint]. 2024 Sep 24:2024.09.22.24314165. doi: 10.1101/2024.09.22.24314165. medRxiv. 2024. PMID: 39371173 Free PMC article. Preprint.
• Circulating tumor DNA: from discovery to clinical application in breast cancer.
  Xu J, Gao H, Guan X, Meng J, Ding S, Long Q, Yi W. Xu J, et al. Front Immunol. 2024 Apr 30;15:1355887. doi: 10.3389/fimmu.2024.1355887. eCollection 2024. Front Immunol. 2024. PMID: 38745646 Free PMC article. Review.
• Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer.
  Zheng LW, Liu CC, Yu KD. Zheng LW, et al. J Hematol Oncol. 2023 Dec 18;16(1):123. doi: 10.1186/s13045-023-01522-5. J Hematol Oncol. 2023. PMID: 38110976 Free PMC article. Review.
• Unravelling cancer subtype-specific driver genes in single-cell transcriptomics data with CSDGI.
  Huang M, Ma J, An G, Ye X. Huang M, et al. PLoS Comput Biol. 2023 Dec 14;19(12):e1011450. doi: 10.1371/journal.pcbi.1011450. eCollection 2023 Dec. PLoS Comput Biol. 2023. PMID: 38096269 Free PMC article.
• Transforming Diagnosis and Therapeutics Using Cancer Genomics.
  Mehmood S, Aslam S, Dilshad E, Ismail H, Khan AN. Mehmood S, et al. Cancer Treat Res. 2023;185:15-47. doi: 10.1007/978-3-031-27156-4_2. Cancer Treat Res. 2023. PMID: 37306902

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource